Targeting DLL-3 for a variety of potential lung cancer therapies

In this article, ACROBiosystems demonstrates how DLL-3 could become a potential target for a variety of lung cancer therapies.

Related Keywords

Susan Winandy ,Nan Fang ,Alex Smith ,Martin Peter ,Amgen ,Proceedings Of The National Academy Sci ,Journal Of Southern Medical University ,Clinical Cancer Research ,Sponsored Content ,Provide His ,His Tag ,Labeled Human ,Human Igg ,Southern Medical University ,National Academy ,Biology Cell ,Thoracic Oncology ,Half Life Extended ,Targeted Bispecifict Cell Engager ,Shows High Potency ,Preclinical Models ,Small Cell Lung ,Clinical Cancer ,Content Policy ,News Medical Net ,Lung Cancer ,Bill 3 ,